{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:29:20Z","timestamp":1786998560829,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vph.2026.107616","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T21:03:17Z","timestamp":1777842197000},"page":"107616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chronic venous insufficiency and cardiovascular risk: Marker or bystander?"],"prefix":"10.1016","volume":"163","author":[{"given":"Alfredo","family":"Mauriello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Correra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Del Guercio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Caturano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Riegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"D'Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2026.107616_bb0005","doi-asserted-by":"crossref","DOI":"10.1111\/iwj.14405","article-title":"Chronic venous insufficiency and venous leg ulcers: aetiology, on the pathophysiology-based treatment","volume":"21","author":"Krizanova","year":"2024","journal-title":"Int. Wound J."},{"key":"10.1016\/j.vph.2026.107616_bb0010","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1093\/eurheartj\/ehab495","article-title":"Chronic venous insufficiency, cardiovascular disease, and mortality: a population study","volume":"42","author":"Prochaska","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2026.107616_bb0015","first-page":"567","article-title":"Varicose veins and chronic venous disease","volume":"39","author":"Alsaigh","year":"2021","journal-title":"Cardiol. Clin."},{"key":"10.1016\/j.vph.2026.107616_bb0020","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jvs.2004.09.027","article-title":"Revision of the CEAP classification for chronic venous disorders: consensus statement","volume":"40","author":"Ekl\u00f6f","year":"2004","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.vph.2026.107616_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17010059","article-title":"Emerging pharmacological interventions for chronic venous insufficiency: a comprehensive systematic review and meta-analysis of efficacy, safety, and therapeutic advances","volume":"17","author":"Miguel","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vph.2026.107616_bb0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/0268355515589224","article-title":"The influence of age and gender on venous symptomatology. An epidemiological survey in Belgium and Luxembourg","volume":"31","author":"Vuylsteke","year":"2016","journal-title":"Phlebology"},{"key":"10.1016\/j.vph.2026.107616_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.113.006898","article-title":"Chronic venous insufficiency","volume":"130","author":"Eberhardt","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2026.107616_bb0040","doi-asserted-by":"crossref","DOI":"10.23736\/S0392-9590.19.04216-0","article-title":"Benefits of Venoactive drug therapy in surgical or Endovenous treatment for varicose veins: a systematic review","volume":"38","author":"Mansilha","year":"2019","journal-title":"Int. Angiol."},{"key":"10.1016\/j.vph.2026.107616_bb0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1024\/0301-1526\/a000946","article-title":"Post-thrombotic syndrome","volume":"50","author":"Vison\u00e0","year":"2021","journal-title":"Vasa"},{"key":"10.1016\/j.vph.2026.107616_bb0050","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.3390\/jcm14196695","article-title":"The crucial role of tinzaparin in managing venous thromboembolism in the Cancer population","volume":"14","author":"Mauriello","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.vph.2026.107616_bb0055","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.55742","article-title":"May-Thurner syndrome: The worst-case scenario","author":"Costa","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.vph.2026.107616_bb0060","doi-asserted-by":"crossref","DOI":"10.23736\/S0392-9590.24.05339-2","article-title":"Glycocalyx disruption, endothelial dysfunction and vascular remodeling as underlying mechanisms and treatment targets of chronic venous disease","volume":"43","author":"Diaz","year":"2025","journal-title":"Int. Angiol."},{"key":"10.1016\/j.vph.2026.107616_bb0065","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI83083","article-title":"Endothelial fluid shear stress sensing in vascular health and disease","volume":"126","author":"Baeyens","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2026.107616_bb0070","first-page":"303","article-title":"Importancia M\u00e9dica Del Glucoc\u00e1liz Endotelial","volume":"83","author":"Frati-Munari","year":"2013","journal-title":"Arch. Cardiol. Mex."},{"key":"10.1016\/j.vph.2026.107616_bb0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12195-013-0273-z","article-title":"Heparan Sulfate regrowth profiles under laminar shear flow following enzymatic degradation","volume":"6","author":"Giantsos-Adams","year":"2013","journal-title":"Cell. Mol. Bioeng."},{"key":"10.1016\/j.vph.2026.107616_bb0080","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s13555-023-00908-0","article-title":"Narrative review of the pathogenesis of stasis dermatitis: an inflammatory skin manifestation of venous hypertension","volume":"13","author":"Silverberg","year":"2023","journal-title":"Dermatol. Ther. (Heidelb.)"},{"key":"10.1016\/j.vph.2026.107616_bb0085","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0268355516632998","article-title":"Pathophysiology of wound healing and alterations in venous leg ulcers-review","volume":"31","author":"Raffetto","year":"2016","journal-title":"Phlebol. J. Venous Disease"},{"key":"10.1016\/j.vph.2026.107616_bb0090","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.115.227330","article-title":"Matrix metalloproteinases as regulators of vein structure and function: implications in chronic venous disease","volume":"355","author":"MacColl","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2026.107616_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11560-021-00487-1","article-title":"Thrombotische Mikroangiopathie","volume":"16","author":"G\u00e4ckler","year":"2021","journal-title":"Nephrologe"},{"key":"10.1016\/j.vph.2026.107616_bb0100","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12877-021-02528-9","article-title":"The association between chronic venous disease and measures of physical performance in older people: a population-based study","volume":"21","author":"Sinikumpu","year":"2021","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.vph.2026.107616_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1570161111666131126144025","article-title":"Sulodexide Down-regulates the release of cytokines, chemokines, and leukocyte Colony stimulating factors from human macrophages: role of glycosaminoglycans in inflammatory pathways of chronic venous disease","volume":"12","author":"Mannello","year":"2014","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2026.107616_bb0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/ijms20020244","article-title":"YC-1 prevents tumor-associated tissue factor expression and procoagulant activity in hypoxic conditions by inhibiting P38\/NF-\u039aB Signaling pathway","volume":"20","author":"Hsieh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2026.107616_bb0115","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbrc.2016.11.119","article-title":"Hypoxanthine causes endothelial dysfunction through oxidative stress-induced apoptosis","volume":"482","author":"Kim","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2026.107616_bb0120","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3390\/biomedicines12122720","article-title":"Mitochondrial dysfunction in atrial fibrillation: the need for a strong pharmacological approach","volume":"12","author":"Mauriello","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.vph.2026.107616_bb0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13221-014-0024-5","article-title":"Cellular and molecular basis of venous insufficiency","volume":"6","author":"Pocock","year":"2014","journal-title":"Vasc. Cell"},{"key":"10.1016\/j.vph.2026.107616_bb0130","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/jcm14051652","article-title":"Serum lipids, inflammation, and the risk of atrial fibrillation: pathophysiological links and clinical evidence","volume":"14","author":"Mauriello","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.vph.2026.107616_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2024.112309","article-title":"Angiotensin II: role in oxidative stress, endothelial dysfunction, and diseases","volume":"592","author":"Ajoolabady","year":"2024","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.vph.2026.107616_bb0140","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3390\/life13091888","article-title":"Anti-inflammatory and anticancer effects of anticoagulant therapy in patients with malignancy","volume":"13","author":"Russo","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.vph.2026.107616_bb0145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1024\/0301-1526\/a000335","article-title":"Pathogenesis of varicose veins - lessons from biomechanics","volume":"43","author":"Pfisterer","year":"2014","journal-title":"Vasa"},{"key":"10.1016\/j.vph.2026.107616_bb0150","doi-asserted-by":"crossref","DOI":"10.5114\/aoms.2019.85232","article-title":"Evaluation of chronic inflammation in the aetiology of venous insufficiency by investigating cytomegalovirus DNA","author":"Beyaz","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.vph.2026.107616_bb0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2016.04.001","article-title":"Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox Signaling","volume":"100","author":"Brand","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2026.107616_bb0160","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/jdv.18770","article-title":"Polymorphisms in some proinflammatory genes (<scp>TNF\u03b1<\/Scp> and \u03b2, <scp>IL<\/Scp> \u22121\u03b2, <scp>IL<\/Scp> \u22126, <scp>ADAM17<\/Scp>) in severe chronic venous disease","volume":"37","author":"Slonkov\u00e1","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.vph.2026.107616_bb0165","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1161\/CIRCULATIONAHA.106.675348","article-title":"Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb","volume":"115","author":"Mellor","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2026.107616_bb0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1523-1747.1998.00113.x","article-title":"Levels of tumor necrosis factor-\u03b1 (TNF-\u03b1) and soluble TNF receptors in chronic venous leg ulcers \u2013 correlations to healing status","volume":"110","author":"Wallace","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.vph.2026.107616_bb0175","doi-asserted-by":"crossref","DOI":"10.23736\/S0392-9590.17.03820-2","article-title":"Interrelationship between venous and arterial thrombosis","volume":"36","author":"Poredo\u0161","year":"2017","journal-title":"Int. Angiol."},{"key":"10.1016\/j.vph.2026.107616_bb0180","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00380-010-0111-3","article-title":"In patients with idiopathic venous thrombosis, Interleukin-10 is decreased and related to endothelial dysfunction","volume":"26","author":"Poredos","year":"2011","journal-title":"Heart Vessel."},{"key":"10.1016\/j.vph.2026.107616_bb0185","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.104.513085","article-title":"C-reactive protein, Interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population","volume":"112","author":"Tzoulaki","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2026.107616_bb0190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.atherosclerosis.2005.03.007","article-title":"Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: atherosclerosis risk in communities study","volume":"183","author":"Hoogeveen","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2026.107616_bb0195","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/CIRCULATIONAHA.106.683722","article-title":"\u03922-microglobulin as a biomarker in peripheral arterial disease","volume":"116","author":"Wilson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2026.107616_bb0200","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.avsg.2023.03.013","article-title":"Advanced levels of chronic venous insufficiency are related to an increased in arterial stiffness","volume":"96","author":"Nogueira","year":"2023","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.vph.2026.107616_bb0205","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0749-3797(18)31203-0","article-title":"The epidemiology of varicose veins: the Framingham study","volume":"4","author":"Brand","year":"1988","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.vph.2026.107616_bb0210","article-title":"The cardiovascular impact of chronic venous disease: a systematic review and Meta-analysis","volume":"14","author":"Del R\u00edo-Sol\u00e1","year":"2026","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"10.1016\/j.vph.2026.107616_bb0215","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jvsv.2021.08.021","article-title":"Association of Chronic Venous Disease with major adverse cardiovascular events","volume":"10","author":"Singh","year":"2022","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"10.1016\/j.vph.2026.107616_bb0220","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/02683555231162294","article-title":"Association between cardiac conditions with venous leg ulcers in patients with chronic venous insufficiency","volume":"38","author":"Pizano","year":"2023","journal-title":"Phlebol. J. Venous Disease"},{"key":"10.1016\/j.vph.2026.107616_bb0225","first-page":"452","article-title":"The risk of congestive heart failure is increased in persons with varicose veins","volume":"28","author":"M\u00e4kivaara","year":"2009","journal-title":"Int. Angiol."},{"key":"10.1016\/j.vph.2026.107616_bb0230","article-title":"Association of Varicose Veins with the risk of heart failure: a nationwide cohort study","volume":"20","author":"Kim","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2026.107616_bb0235","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2510357","article-title":"Causal association of chronic venous insufficiency and cardiovascular diseases: a univariable and multivariable mendelian randomization study","volume":"25","author":"Guo","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.vph.2026.107616_bb0240","article-title":"2025 SCAI clinical practice guidelines for the management of chronic venous disease","volume":"4","author":"Attaran","year":"2025","journal-title":"J. Soc. Cardiovasc. Angiogr. Intervent."},{"key":"10.1016\/j.vph.2026.107616_bb0245","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jvsv.2020.04.006","article-title":"Effect of obesity on chronic venous insufficiency treatment outcomes","volume":"8","author":"Deol","year":"2020","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"10.1016\/j.vph.2026.107616_bb0250","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.avsg.2023.09.098","article-title":"Diabetes, hypertension, and smoking do not affect outcomes of iliofemoral vein stenting for chronic proximal venous outflow obstruction","volume":"99","author":"Kang","year":"2024","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.vph.2026.107616_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2024.107375","article-title":"Inferior vena cava filters: concept review and summary of current guidelines","volume":"155","author":"Visconti","year":"2024","journal-title":"Vasc. Pharmacol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:32:43Z","timestamp":1786995163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189126000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":51,"alternative-id":["S1537189126000364"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2026.107616","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic venous insufficiency and cardiovascular risk: Marker or bystander?","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2026.107616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107616"}}